NFE2L2 and cancer: Activation of NRF2 in cancer cells imposes a glutamine addition that is caused by an increased dependency on exogenous glutamine through increased consumption of glutamate for glutathione synthesis and glutamate secretion by xCT antiporter system, thus limiting glutamate availability for the TCA cycle and other biosynthesis pathway [89].